Here’s what three scientists from the Department of Health and Human Services said in the abstract — or summary — of their findings submitted with the patent application: “The cannabinoids are found to have particular application as neuroproectants, for example in limiting neurological damage following ischemic insults, such as stroke or trauma, or the treatment of neurological diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”
Posted on: Thu, 12 Sep 2013 02:41:42 +0000
Trending Topics
Recently Viewed Topics
© 2015